Assessing the Impact of the COVID ‐19 Pandemic on Relative Incidence Rates in United States Claims Data

Documenti analoghi

• Comparing Two Approaches to Identify Individuals with Severe Asthma in United States Claims Data
  di: Julie Barberio, et al.
  Pubblicazione: (2025)
• Psychiatric Medication Adherence in the United States Before and During the COVID ‐19 Pandemic
  di: Rebecca C. Rossom, et al.
  Pubblicazione: (2025)
• Development and Validation of Claims‐Based Algorithms for Conjunctivitis and Keratitis
  di: Andrea K. Chomistek, et al.
  Pubblicazione: (2024)
• Monitoring Pregnancies Exposed to Galcanezumab for Migraine in a United States Administrative Claims Database
  di: Sarah R. Hoffman, et al.
  Pubblicazione: (2024)
• Impact of COVID ‐19 Restrictions on Nationwide Antipsychotic Use: Results From the Trends in Drug Utilization During COVID ‐19 Pandemic in Turkey ( PANDUTI ‐ TR ) Study
  di: Caner Vizdiklar, et al.
  Pubblicazione: (2026)